AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33957371 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasburicase (1.5−3 mg) with allopurinol 300 mg daily
Number of subjects: 24
Study 32394423 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion dysregulation (assessed by the Difficulties in Emotion Regulation Scale - DERS)
Number of subjects: 259
Study 32394423 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion dysregulation subscales
Number of subjects: 259
Study 32394423 — intervention group
Group type: EXPERIMENTAL
Intervention: Distress tolerance and intolerance of uncertainty
Number of subjects: 259
Study 34260549 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Rational Emotive Behavior Therapy (group REBT)
Number of subjects: 160
Study 34260549 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 160
Study 32213019 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics for acute and chronic pouchitis
Number of subjects: 0
Study 32213019 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti‐tumour necrosis factor
Number of subjects: 0
Study 32213019 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture
Number of subjects: 0
Study 32213019 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent ileostomy
Number of subjects: 0
Study 35567829 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity-based training
Number of subjects: 40
Study 35567829 — intervention group
Group type: COMPARATOR
Intervention: Strengthening exercises
Number of subjects: 40
Study 33612439 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplementation (16 g/d)
Number of subjects: 123
Study 33612439 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein supplementation (16 g/d)
Number of subjects: 123
Study 33612439 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey-soy blended protein supplementation (16 g/d)
Number of subjects: 123
Study 33612439 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained habitual diets)
Number of subjects: 123
Study 32787921 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified approach
Number of subjects: 31
Study 32787921 — intervention group
Group type: COMPARATOR
Intervention: Conventional approach
Number of subjects: 31
Study 36277594 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential ventilation therapy
Number of subjects: 96
Study 36277594 — intervention group
Group type: COMPARATOR
Intervention: Conventional invasive mechanical ventilation
Number of subjects: 96
Study 33902955 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab 1200 mg every 3 weeks
Number of subjects: 0
Study 33902955 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (vinflunine 320 mg/m2, paclitaxel 175 mg/m2, or docetaxel 75 mg/m2 according to investigator choice) every 3 weeks
Number of subjects: 0
Study 33902955 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 0
Study 33902955 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 35197538 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted discharge education (VADE) program
Number of subjects: 31
Study 35197538 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy program
Number of subjects: 31
Study 33015732 — intervention group
Group type: EXPERIMENTAL
Intervention: FO salmon (2 portions/week)
Number of subjects: 51
Study 33015732 — intervention group
Group type: EXPERIMENTAL
Intervention: RO salmon (2 portions/week)
Number of subjects: 51
Study 33015732 — intervention group
Group type: COMPARATOR
Intervention: Control (no additional salmon)
Number of subjects: 51
Study 34195784 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia with postoperative epidural analgesia
Number of subjects: 1712
Study 34195784 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone with postoperative intravenous analgesia
Number of subjects: 1712
Study 34195784 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia
Number of subjects: 1712
Study 34195784 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 1712
Study 33170240 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine e‐cigarettes plus counseling
Number of subjects: 376
Study 33170240 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonnicotine e‐cigarettes plus counseling
Number of subjects: 376
Study 33170240 — intervention group
Group type: COMPARATOR
Intervention: Counseling alone
Number of subjects: 376
Study 35780458 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care worker training intervention (SISTAQUIT) including ABCD approach, educational resource package, free oral nicotine replacement therapy, implementation support, and trial implementation training
Number of subjects: 21
Study 35780458 — intervention group
Group type: COMPARATOR
Intervention: Usual care provided by health care providers in control group services
Number of subjects: 21
Study 35780458 — intervention group
Group type: EXPERIMENTAL
Intervention: Health service process evaluations; knowledge, attitudes, and practices of health care providers; longer term abstinence; perinatal outcomes; respiratory outcomes for babies (to six months)
Number of subjects: 21
Study 32541300 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative therapeutic suggestion
Number of subjects: 30
Study 32541300 — intervention group
Group type: COMPARATOR
Intervention: Routine perioperative care
Number of subjects: 30
Study 32703215 — intervention group
Group type: EXPERIMENTAL
Intervention: Health worker knowledge of artesunate treatment policies
Number of subjects: 697
Study 32703215 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of dosing intervals
Number of subjects: 697
Study 32703215 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of preparation solutions
Number of subjects: 697
Study 32703215 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of artesunate dose for weight categories
Number of subjects: 697
Study 32703215 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of preferred route of administration
Number of subjects: 697
Study 32703215 — intervention group
Group type: COMPARATOR
Intervention: Display of artesunate administration posters
Number of subjects: 697
Study 32703215 — intervention group
Group type: COMPARATOR
Intervention: Paediatric ward allocation
Number of subjects: 697
Study 32703215 — intervention group
Group type: COMPARATOR
Intervention: Repeated surveys
Number of subjects: 697
Study 32703215 — intervention group
Group type: COMPARATOR
Intervention: Availability of artesunate at hospitals
Number of subjects: 697
Study 32703215 — intervention group
Group type: COMPARATOR
Intervention: Health worker pre-service training
Number of subjects: 697
Study 32703215 — intervention group
Group type: COMPARATOR
Intervention: In-service malaria case-management training
Number of subjects: 697
Study 32703215 — intervention group
Group type: COMPARATOR
Intervention: Access to malaria guidelines
Number of subjects: 697
Study 35473394 — intervention group
Group type: EXPERIMENTAL
Intervention: Low load working memory maintenance with distractors
Number of subjects: 22
Study 35473394 — intervention group
Group type: EXPERIMENTAL
Intervention: High load working memory maintenance
Number of subjects: 22
Study 35473394 — intervention group
Group type: COMPARATOR
Intervention: Low load working memory maintenance
Number of subjects: 22
Study 33063157 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypo group (glucose < 3.3 mmol/L)
Number of subjects: 44
Study 33063157 — intervention group
Group type: COMPARATOR
Intervention: Non-hypo group (glucose ≥ 3.3 mmol/L)
Number of subjects: 44
Study 32931668 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO2)
Number of subjects: 50
Study 32931668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 35961347 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 0
Study 35961347 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32030916 — intervention group
Group type: EXPERIMENTAL
Intervention: General stress
Number of subjects: 110
Study 32030916 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting distress
Number of subjects: 110
Study 32030916 — intervention group
Group type: EXPERIMENTAL
Intervention: Household chaos
Number of subjects: 110
Study 36367227 — intervention group
Group type: EXPERIMENTAL
Intervention: Young Person's Face IT (YPF), a web‐based psychosocial intervention
Number of subjects: 102
Study 36367227 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 102
Study 35725616 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation Gaming System (RGS) combined with standard care
Number of subjects: 90
Study 35725616 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 90
Study 32199548 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counseling
Number of subjects: 570
Study 32199548 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-Step participation
Number of subjects: 570
Study 32199548 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counseling and 12-Step participation interaction
Number of subjects: 570
Study 32199548 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant age
Number of subjects: 570
Study 32199548 — intervention group
Group type: EXPERIMENTAL
Intervention: Employment status
Number of subjects: 570
Study 32199548 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy
Number of subjects: 570
Study 35108175 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary transvenous diaphragm neurostimulation (treatment)
Number of subjects: 112
Study 35108175 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 112
Study 33753882 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 100
Study 33753882 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 100
Study 33753882 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 100
Study 32161036 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 0
Study 32161036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34266934 — intervention group
Group type: EXPERIMENTAL
Intervention: activL
Number of subjects: 283
Study 34266934 — intervention group
Group type: COMPARATOR
Intervention: ProDisc-L
Number of subjects: 283
Study 35348880 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (20 min oral presentation based on literature and international guidelines)
Number of subjects: 60
Study 35348880 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 60
Study 33741648 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-THP PSMA PET/CT
Number of subjects: 49
Study 32818953 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory substitution device
Number of subjects: 7
Study 32818953 — intervention group
Group type: COMPARATOR
Intervention: White cane
Number of subjects: 7
Study 32818953 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both (sensory substitution device and white cane)
Number of subjects: 7
Study 35321960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic femoral head with HXPLE insert
Number of subjects: 143
Study 35321960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic femoral head 40mm
Number of subjects: 143
Study 35321960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic femoral head 44mm
Number of subjects: 143
Study 33988528 — intervention group
Group type: EXPERIMENTAL
Intervention: Posteromedial quadratus lumborum block
Number of subjects: 116
Study 33988528 — intervention group
Group type: COMPARATOR
Intervention: Wound infiltration
Number of subjects: 116
Study 33988528 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 116
Study 32631301 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with parecoxib sodium (group DP)
Number of subjects: 120
Study 32631301 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 120
Study 32631301 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib sodium (group P)
Number of subjects: 120
Study 32631301 — intervention group
Group type: COMPARATOR
Intervention: Control group (group N)
Number of subjects: 120
Study 35504795 — intervention group
Group type: EXPERIMENTAL
Intervention: Seating intervention by experts in addition to conventional rehabilitation (Group 2)
Number of subjects: 19
Study 35504795 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation (Group 1)
Number of subjects: 19
Study 35420589 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + app-based MT
Number of subjects: 80
Study 35420589 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 80
Study 33905530 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) plus radiation therapy (RT)
Number of subjects: 1463
Study 33905530 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 1463
Study 36026532 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent de-frailing intervention (exercise, cognitive stimulation, protein supplementation, iron replacement)
Number of subjects: 135
Study 36026532 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 135
Study 34444980 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum PS128 (PS128)
Number of subjects: 40
Study 34444980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35971210 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person contact only and both phone and in-person contact
Number of subjects: 75
Study 35971210 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention analysis
Number of subjects: 75
Study 35971210 — intervention group
Group type: EXPERIMENTAL
Intervention: Average number of GVs attended
Number of subjects: 75
Study 35971210 — intervention group
Group type: EXPERIMENTAL
Intervention: GV attendance
Number of subjects: 75
Study 35971210 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported motivating factors
Number of subjects: 75
Study 33674675 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted rehabilitation
Number of subjects: 32
Study 33674675 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study 34275765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart Cherry (TC) concentrate (50 tart cherries), 1 Oz in 8 Oz water daily for 6 weeks
Number of subjects: 48
Study 34275765 — intervention group
Group type: COMPARATOR
Intervention: Placebo (syrup)
Number of subjects: 48
Study 33639391 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patches (received at baseline)
Number of subjects: 999
Study 33639391 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional NRT purchase
Number of subjects: 999
Study 33639391 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in free-of-charge NRT
Number of subjects: 999
Study 35655647 — intervention group
Group type: EXPERIMENTAL
Intervention: Jodhpur technique (JT)
Number of subjects: 32
Study 35655647 — intervention group
Group type: COMPARATOR
Intervention: Split-thickness skin grafting (STSG)
Number of subjects: 32
Study 32998924 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical chlorhexidine 0.2%
Number of subjects: 0
Study 32998924 — intervention group
Group type: COMPARATOR
Intervention: Topical natamycin 5%
Number of subjects: 0
Study 33917778 — intervention group
Group type: EXPERIMENTAL
Intervention: Measured Resting Metabolic Rate (mRMR) dietary intervention
Number of subjects: 54
Study 33917778 — intervention group
Group type: COMPARATOR
Intervention: Estimated Resting Metabolic Rate (eRMR) dietary intervention
Number of subjects: 54
Study 35152940 — intervention group
Group type: EXPERIMENTAL
Intervention: Moulded cast (n=255)
Number of subjects: 500
Study 35152940 — intervention group
Group type: COMPARATOR
Intervention: Surgical fixation with K-wires (n=245)
Number of subjects: 500
Study 34628741 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and rehabilitation training
Number of subjects: 20
Study 34628741 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation training
Number of subjects: 20
Study 34628741 — intervention group
Group type: COMPARATOR
Intervention: Cerebral palsy group
Number of subjects: 20
Study 35222018 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led self-care education (two face-to-face educational sessions at enrollment and on week 12)
Number of subjects: 75
Study 35222018 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 75
Study 34872271 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SPB)
Number of subjects: 120
Study 34872271 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous serratus anterior plane block (CSPB)
Number of subjects: 120
Study 34872271 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA)
Number of subjects: 120
Study 36348276 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine (60 mg/day)
Number of subjects: 188
Study 36348276 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 36400384 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (nCRT)
Number of subjects: 264
Study 36400384 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (nCT) followed by minimally invasive esophagectomy (MIE)
Number of subjects: 264
Study 36400384 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (nCT)
Number of subjects: 264
Study 34614123 — intervention group
Group type: EXPERIMENTAL
Intervention: injectable platelet-rich fibrin (i-PRF)
Number of subjects: 24
Study 34614123 — intervention group
Group type: COMPARATOR
Intervention: methylprednisolone acetate (corticosteroids)
Number of subjects: 24
Study 34935935 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (simulated high altitude at 4200 m)
Number of subjects: 7
Study 34935935 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (sea-level conditions)
Number of subjects: 7
Study 33252671 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital Consultation (HC)
Number of subjects: 342
Study 33252671 — intervention group
Group type: COMPARATOR
Intervention: Usual Hospital Care (UHC)
Number of subjects: 342
Study 35834380 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid thoracolumbar orthosis (Boston brace)
Number of subjects: 57
Study 35834380 — intervention group
Group type: COMPARATOR
Intervention: Elastic lumbar support
Number of subjects: 57
Study 35834380 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 57
Study 34169174 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored video vignettes
Number of subjects: 1393
Study 34169174 — intervention group
Group type: COMPARATOR
Intervention: General clinical trials education (text)
Number of subjects: 1393
Study 35152152 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nafamostat (0.2 mg/kg/h for a maximum of seven days)
Number of subjects: 42
Study 35152152 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nafamostat
Number of subjects: 42
Study 35152152 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 42
Study 34051911 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom Strategies Coaching Model (CSC)
Number of subjects: 2195
Study 34051911 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 2195
Study 35435843 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol septal ablation
Number of subjects: 134
Study 32187789 — intervention group
Group type: COMPARATOR
Intervention: Biomedical-focused education and exercise therapy
Number of subjects: 64
Study 36368427 — intervention group
Group type: EXPERIMENTAL
Intervention: Baroque music (BM)
Number of subjects: 26
Study 36368427 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music (CM)
Number of subjects: 26
Study 36368427 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 26
Study 36368427 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of perceived pain
Number of subjects: 26
Study 33639833 — intervention group
Group type: EXPERIMENTAL
Intervention: PATINA algorithm and decision support tool
Number of subjects: 6500
Study 32321551 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin plus fenofibrate (rosuvastatin 10 mg plus fenofibrate 160 mg/day)
Number of subjects: 106
Study 32321551 — intervention group
Group type: COMPARATOR
Intervention: Statin alone (rosuvastatin 10 mg/day)
Number of subjects: 106
Study 34587231 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher insulin concentration 30 min after a 75-g oral glucose load (insulin-30)
Number of subjects: 243
Study 34587231 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater HOMA-IR
Number of subjects: 243
Study 34587231 — intervention group
Group type: COMPARATOR
Intervention: Results from FS2
Number of subjects: 243
Study 32684106 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartPrompt (SP)
Number of subjects: 10
Study 32684106 — intervention group
Group type: COMPARATOR
Intervention: Unprompted (UP)
Number of subjects: 10
Study 34565433 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 83
Study 34565433 — intervention group
Group type: COMPARATOR
Intervention: Mefenamic acid
Number of subjects: 83
Study 34565433 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 83
Study 32587742 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication tool about diet used in public health nurse consultations
Number of subjects: 250
Study 32587742 — intervention group
Group type: COMPARATOR
Intervention: Standard consultations
Number of subjects: 250
Study 36265371 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led eHealth cardiac rehabilitation (CR) program
Number of subjects: 20
Study 32912741 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma coated GP lenses
Number of subjects: 233
Study 32912741 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing diameter of GP lenses (10.1 mm or 10.6 mm)
Number of subjects: 233